Bioethics News

‘Miracle’ Hepatitis C Drugs ‘May Have No Clinical Effect’

Review concludes drugs, costing £30k per patient, hailed as cure for potentially fatal liver disease may clear virus from blood, but there is no evidence they prevent harm or save lives

Source: Bioethics Bulletin by the Berman Institute of Bioethics.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.